Simple techniques
for controlling interference from binding proteins in serum, such as thyroxine-binding globulin, in radioimmunoassay for triiodothyronine (13) have been evaluated for their efficacy, and their effect on assay sensitivity and on recovery of added T3. Ethanol precipitation of serum proteins decreased the assay sensitivity, nonspecific binding was increased, and recoveries of added T3 were inconsistent. Heat-inactivation of thyroxine-binding globulin or use of 8-anilino-1-naphthalene sulfonic acid (ANS) to displace 13 from thyroxine-binding globulin produced comparable recovery rates. The heat-inactivation method slightly decreased the sensitivity of the assay and prolonged the procedure, whereas use of ANS is simple, and the assay sensitivity is maintained. When sera contain a high concentration of thyroxine-binding globulin, a fixed concentration of ANS (175 g/100 d of serum) might be too low to displace 13 from all its binding sites, but a concentration of ANS greater than 200 ig/100 tI of serum interferes with 13 quantitation by competitively binding to the antibodies.
The cross-reactivity of thyroxine to T3-antibodies varies with the antiserum. Thyroxine-binding globulin appears to be the only protein in serum that competes with the antibody for 13 binding.
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Before triiodothyronine (T3) can be measured in blood samples by radioimmunoassay, it must be freed from binding to serum proteins.1 Several methods have been used to do so. Column chromatography (1) is too involved for routine use in the clinical laboratory. Simpler methods include heat-inactivation of the binding proteins (2) , ethanol extraction ofT3 (3) , and use of various chemical blocking agents such as thyroxine (4), tetrachlorothyronine
and 8-anilino-1-naphthalene sulfonic acid (ANS) (9,
In this paper, we compare the effectiveness of three simple methods (ANS, heat-inactivation, and ethanol precipitation) in preventing interference from T3-binding proteins in the radioimmunoassay of T3. Using two different T3-specific antisera, we determined the recovery of T3 added to serum in various assay systems.
Materials and Methods
Reagents and Sera [1251] triiodothyronine (100 Ci/g) was purchased from Industrial Nuclear Co., Inc., St. Louis, Mo. 63114. The purity of the tracer was greater than 95% on delivery,
and there was no chromatographic deterioration during its storage at 4 #{176}C. Two different antisera to T3 were the gift from two independent investigators. Both were produced in rabbits by immunization with T3 coupled to human serum albumin, with carbodiimide as the coupling reagent. The unlabeled T3 and thyroxine used in our studies were purchased from Sigma Chemical Co., St. Louis, Mo.
63178. A stock solution ofT3 (1 tg/ml of ethanol) was stable at -20 #{176}C for at least six months.
Goat antirabbit-IgG serum was produced in our laboratory. zg of T4 per deciliter): To each tube were added 100 tl of T3-free serum and sufficient barbital buffer to make a final volume of 300 z1.
3. Heat-inactivation of serum TBG: A set of tubes duplicating those of set 2 was heated in water-bath at 60 #{176}C for 2 h. Although this set contained serum, T3 binding to TBG was prevented by this heat denaturing of the protein (2, 11).
Prevention of T3 binding to TBG by chemical displacement:
To each tube were added 100 l of T3-free serum and sufficient barbital buffer containing 175 zg of ANS to make a final volume of 300 zl.
5. Serum protein precipitationand T3 extraction with ethanol:
To each tube, 100 l of T3-free serum was added.
After 20 mm of equilibration at room temperature, the serum in each tube was deproteinized by adding 500 zl of ethanol and mixing on a vortex-type mixer. The precipitated protein was centrifuged at 2500 rpm for 10 mm, and the supernatant fluid was decanted into a new tube and then evaporated in a stream of warm (45 #{176}C g of ANS to give a final volume of 300 zl.
100
of TBG-free serum that contained 60 pg of T3 and sufficient barbital buffer without ANS to give a final volume of 300 l. 3 . The TBG-free serum and barbital buffer containing 175 g of ANS to give a final volume of 300 l.
All tubes were then cooled to 4 #{176}C. Except for the first tube in each series, which contained no T3, 100 tl of antiserum (2000-folddilutionof the originalantiserum) was added to all tubes; 100 1d of barbital buffer was added to the firsttube instead. Finally, 100 l of a solution of tracer containing 100 tg of nor- ANS. All tubes were centrifuged at 2500 rpm for 25 mm. After the supernatant fluid was aspirated, the same counting method was used to determine the radioactivity in the precipitate.
Calculation.
The ratio between counts for the precipitate (B) and total (T) counts for each tube repre- In
Tests for accuracy
by the T3 recovery procedure.
A known quantity of T3 was added to and mixed with 100 zl of serum samples. The total T3 was quantitated in samples with or without T3 added by the various methods used to control the binding proteins, and the percentage of the added T3 accounted for was calculated. In one serum from a patient with partial TBG deficiency, 300 pg of T3 was mixed with 100 jl of serum; the recovery of T3 was determined with use of 100, 50, 25, and 10 il of the sample.
Cross-reactivity of T3 antibodies with T4. Known quantities of thyroxine, equivalent to a range from normal to the highest T4 concentration in serum encountered in thyrotoxicosis (10-50 tgIdeciliter), were assayed by using Ta-antiserum in a serum-free buffer system. The percent cross-reactivity of thyroxine as T3 was calculated. Both antisera were tested.
Binding of ANS to T3 antibodies.
The interference of ANS in the assay by binding to the T3 antibody was determined in a serum-free buffer system containing various amounts of ANS (100-500 jig/tube). Both antisera were tested. Figure 1 depicts the T3 binding and dose-displacement relationship curves for two antisera. With either antiserum, a serum-free system resulted in the most sensitive curves. T3 doses from 20 to 100 pg T3/tube produced the steepest slope. In contrast, the system containing untreated serum with normal TBG capacity showed the poorest maximal binding to antibodies and displacement with T3. Use of any of the three methods (ANS displacement, heat-inactivation, or ethanol precipitation) to overcome the T3-binding effect of serum proteins improved the sensitivity of dose-binding curves. Between T3 doses of 20 and 100 pg the sensitivity of curves was better with the ANS-treated and heat-inactivated sera than with the ethanol-precipitated serum samples when antiserum A was used. However, when antiserum B was tested, the ANS treatment resulted in a more sensitive curve than those produced by heat inactivation and ethanol precipitation.
Results
Both antisera A and B were used at an initial dilution of 2000-fold and at a final dilution of 10 000-fold. Antiserum A has an obviously higher titer of T3 antibodies than does antiserum B. Nevertheless, both antisera are similar with regard to the effects of serum protein and the effectiveness of various treatments on the sensitivity of T3 dose displacement and binding relationship curves. The percent nonspecific bindings in various assay systems are shown in Table 2 . The presence of serum protein in the system significantly reduced the nonspecific binding of radioactive T3 (P <.001). Neither addition of ANS to the system nor heat-inactivation changed the nonspecific binding appreciably. Conversely, the highest nonspecific binding was observed in the system where serum protein was precipitated by ethanol and removed from the assay system.
The specific effect of TBG on T3 radioimmunoassay was tested by using serum totally deficient in TBG; the results are shown in Figure 2 . The standard curves with antisera A and B were constructed by the assay system containing T3-free serum with normal TBG capacity and ANS to prevent TBG interference. Based on these standard curves, the TBG deficient serum was estimated to contain 60 pg of T3 per 100 il. When various quantities of T3 (0-250 pg) were added to this TBG-deficient serum and assayed for the total T3, with or without ANS added, all the corrected B/T percentages fell in the expected positions along the standard curves. The serum totally deficient in TBG contains normal amounts of other proteins (11), so these results clearly indicate that of the various T3-binding substances in serum the TBG is the most important interfering protein.
Data presented in Table 3 indicate that, in general, T3 recovery decreased in sera with higher TBG con- The cross-reactivity of thyroxine with the two T3-antisera is shown in Table 4 . For antiserum A the average cross-reactivity with thyroxine is 0.36%; for antiserum B it is 0.085%. This difference indicates that the observed cross-reactivity is not due solely to the possible contamination of the thyroxine standard with T3, but rather represents a difference in the antiserum specificity.
When increased quantities of ANS were added to the serum-free assay system, the corrected B/T ratio decreased steadily ( The ethanol extracts contain lipids which, after evaporation, can no longer be completely redissolved.
The particles in the extract are responsible for the high nonspecific B/T ratio ( Table 2 ). The sensitivity of the assay is also markedly decreased, as the T3-dose binding curves illustrate ( Figure 1 ). Furthermore, ethanol precipitation of TBG requires several additional steps, which are both time-consuming and vulnerable to technical errors, as indicated by the variability ofT3 recovery (Table 3) . Heat-inactivation of TBG prolongs the procedure. The subsequent sensitivity of the assay is slightly lower than for the ANS method (Figure 1 ). The effect of heat-inactivation on the accuracy of assay is comparable to the use of ANS, but the inactivation method provides no advantages. The use of ANS has the merits of simplicity, sensitivity, and relative accuracy for T3 radioimmunoassay in serum samples.
However, the efficiency with which ANS displaces T3 depends on the amount of TBG in the assay sample.
Ideally, the concentration of ANS should be proportionately increased in samples containing higher concentrations of TBG, but a high concentration of ANS in samples with normal or low TBG concentrations will give falsely elevated T3 values because of ANS competitive binding to the antibodies. Therefore, with ANS concentration of 175 g/100
Ml serum, T3 in samples with high TBG content will be underestimated. 
